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Mammalian target of rapamycin complex 1
(mTORC1) controls growth and survival in response
to metabolic cues. Oxidative stress affects mTORC1
via inhibitory and stimulatory inputs. Whereas
downregulation of TSC1-TSC2 activates mTORC1
upon oxidative stress, the molecular mechanism of
mTORC1 inhibition remains unknown. Here, we
identify astrin as an essential negative mTORC1
regulator in the cellular stress response. Upon
stress, astrin inhibits mTORC1 association and
recruits the mTORC1 component raptor to stress
granules (SGs), thereby preventing mTORC1-hyper-
activation-induced apoptosis. In turn, balanced
mTORC1 activity enables expression of stress
factors. By identifying astrin as a direct molecular
link between mTORC1, SG assembly, and the
stress response, we establish a unifying model of
mTORC1 inhibition and activation upon stress.
Importantly, we show that in cancer cells, apoptosis
suppression during stress depends on astrin. Being
frequently upregulated in tumors, astrin is a potentialclinically relevant target to sensitize tumors to
apoptosis.INTRODUCTION
The mammalian target of rapamycin (mTOR) kinase is a central
regulator of growth and metabolism (Polak and Hall, 2009;
Laplante and Sabatini, 2012). mTOR occurs in two multiprotein
complexes, mTOR complex 1 (mTORC1), containing the specific
binding proteins raptor and PRAS40, and mTORC2 contain-
ing rictor and other binding partners. mTORC1 responds to
insulin and amino acids (aa) to control growth and protein
homeostasis via translation and autophagy. mTORC1 has been
also reported to respond to redox stress (Bae et al., 1999; Huang
et al., 2002), but the interplay of inhibitory and activating redox
inputs, as well as the molecular identity of inhibitory redox
signals and their relevance for cellular stress survival, remain
unclear.
In contrast, the mechanisms of mTORC1 induction by insulin
and aa are relatively well understood. In response to aa, the
rag GTPases induce mTORC1-translocation to lysosomes.
Here, mTORC1 can be further activated by insulin via the insulin
receptor (IR) and the insulin-receptor-substrate (IRS), which ac-
tivates class I-phosphoinositide 3-kinases (PI3K). PI3K enablesCell 154, 859–874, August 15, 2013 ª2013 Elsevier Inc. 859
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Figure 1. Astrin Binds to Raptor and Prevents mTORC1 Assembly
(A) Astrin-FLAG overexpression induces raptor levels.
(B) Astrin-FLAG coimmunoprecipitates with raptor, but not with mTOR or
rictor.
(C) Endogenous astrin coimmunoprecipitates with raptor, but not with mTOR
or rictor.
(D) Rapamycin does not alter raptor-astrin binding.
(E) Astrin siRNA induces mTOR-raptor co-IP.
860 Cell 154, 859–874, August 15, 2013 ª2013 Elsevier Inc.Akt-T308 phosphorylation by phosphoinositide-dependent pro-
tein kinase 1 (PDK1). Akt inhibits the tuberous sclerosis complex
1/2 (TSC1-TSC2) dimer, which is the inhibitory GTPase-
activating protein for the small GTPase Rheb. The best charac-
terized mTORC1 substrates are ribosomal protein S6 kinase 1
(S6K1), the 4E-binding protein 4E-BP1, and PRAS40. A
negative-feedback loop (NFL) inhibits PI3K-Akt signaling upon
mTORC1 activation. This NFL is mediated via IRS phosphoryla-
tion by S6K1 and Grb10 phosphorylation by mTORC1.
Under oxidative stress, downregulation of the TSC1-TSC2
complex mediates mTORC1 activation (Yoshida et al., 2011),
whereas AMP-activated protein kinase (AMPK) activation
(Mihaylova and Shaw, 2011) inhibits mTORC1 (Alexander et al.,
2010; Li et al., 2010). Recent evidence suggests that stress gran-
ules (SGs) also play a role in inhibition of mTOR (Luo et al., 2011;
Takahara and Maeda, 2012; Talarek et al., 2010; Wippich et al.,
2013). Oxidative stress induces SGs and P bodies (PBs)
(Thomas et al., 2011). PBs are sites of mRNA decay, whereas
SGs are sites of mRNA storage and triage during stress. SGs
consist of monosomal nontranslating mRNAs and self-associ-
ating proteins, e.g., the RasGAP SH3-binding protein G3BP1,
whose overexpression can be sufficient to induce SGs (Tourrie`re
et al., 2003). SGs are also sites of translation initiation (Buchan
and Parker, 2009), and SGs protect cells against apoptosis by
sequestering signaling molecules (Arimoto et al., 2008).
In this study, we describe astrin as a novel raptor interactor
that mediates mTORC1 inhibition under stress. We show that
astrin is a critical component of mTORC1 signaling, coupling
mTORC1 inhibition and SGs. We demonstrate that astrin inhibits
mTOR-raptor association and recruits raptor to SGs to restrict
mTORC1 activation upon metabolic challenge and redox stress.
By preventing mTORC1 hyperactivation under stress, astrin
mediates antiapoptotic SG functions. At the same time, TSC1-
TSC2 controls astrin expression, and balancedmTORC1 activity
is needed to enable expression of stress response proteins.
Thus, we provide a unifying model in which loss of TSC1-TSC2
mediates mTORC1 activation by stress to allow stress factor
expression, and astrin in a SG-dependent manner prevents
mTORC1 hyperactivation to protect the cell from undergoing
apoptosis.
RESULTS
Astrin Is a Specific Raptor Interactor which Inhibits
mTORC1 Association
To identify novel mTOR regulators, we immunopurified endoge-
nous mTOR, raptor, and rictor from HeLa cells and analyzed the(F) Relative quantitation of mTOR co-IP with raptor (E). Ratio mTOR/raptor for
n = 5 experiments. Data normalized to 1 for siControl, and represented as
mean ± SEM.
(G) Astrin siRNA induces mTOR-raptor association in situ. Nuclei were stained
with DAPI (blue), and PLA was performed for raptor and mTOR (red).
(H) Relative quantitation of mTORC1 assembly in situ without and with astrin
siRNA (G). Dots/cell on control and astrin siRNA slides. Data represented as
median, 25th–75th percentile (box), 5th–95th percentile (whiskers). See Fig-
ure S1C for quantitation of fluorescence intensity.
Experiments performed in HeLa cells. Data representative of at least three
independent experiments. See also Figure S1.
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immunoprecipitates (IPs) by mass spectrometry (MS). We iden-
tified astrin in raptor IPs (Figure S1A available online), but not in
mTOR or rictor IPs. This suggested that astrin binds to raptor,
when the latter is not in a complex with mTOR.
Astrin (UniProtKB: Q96R06) has two isoforms of 160 and
140 kDa. High astrin mRNA levels correlate with negative prog-
nosis in breast and lung cancer (Buechler, 2009; Va¨lk et al.,
2010). We analyzed astrin protein expression in three breast
cancer cell lines. Astrin protein levels positively correlated with
Akt activity, and negatively correlated with phosphorylation of
the mTORC1 substrates PRAS40-S183 and S6K1-T389 (Fig-
ure S1B); raising the question whether astrin exerts an inhibitory
effect on mTORC1.
To further analyze the astrin-raptor interaction, we overex-
pressed astrin-FLAG. Astrin-FLAG overexpression increased the
level of raptor (Figure 1A). Furthermore, astrin-FLAG coimmuno-
precipitated with raptor, but not with mTOR or rictor (Figure 1B),
confirming our MS data. Also endogenous astrin coimmunopuri-
fied with raptor, but not with mTOR or rictor (Figure 1C). Thus,
astrin is a specific interactor of the mTORC1 component raptor.
To test whether mTORC1 activity affects astrin-raptor associ-
ation, we used the allosteric mTORC1 inhibitor rapamycin and
followed astrin-raptor binding by co-IP. Expectedly, rapamycin
inhibited S6K1 phosphorylation, and raptor dissociated from
the mTOR-raptor-complex (Sarbassov et al., 2006), but no effect
on astrin-raptor binding was observed (Figure 1D). Thus,
mTORC1 inhibition does not affect raptor-astrin binding. In
contrast, astrin inhibition affects mTORC1 assembly, as siRNA
knockdown of astrin (siAstrin) resulted in increased mTOR
amounts in raptor IPs (Figures 1E and 1F). To analyze the asso-
ciation of raptor with its binding partners by a complementary
approach, we used proximity ligation assays (PLA) (So¨derberg
et al., 2008). PLA involves single-cell detection of two proximal
proteins in situ. In contrast, IP results represent the average pro-
tein binding in several millions of lysed cells. The physiological
environment and higher number of analyzed events may yield
stronger observable effects in PLAs. We used PLA here, to the
best of our knowledge for the first time, to analyze mTOR
complex dynamics, and this approach revealed enhanced
mTOR-raptor association upon astrin knockdown (Figures 1G
and 1H), which appeared much stronger, as compared to IP.
mTOR-raptor association in PLA was quantified by two different
techniques (dot counting, Figure 1H, and overall intensity deter-
mination, Figure S1C), which yielded comparable results. We
also tested whether astrin overexpression reducesmTOR-raptorFigure 2. Astrin Deficiency Induces mTORC1 and a Negative-Feedbac
(A) Astrin deficiency does not alter S6K1 phosphorylation in mitotic cells but in
chronized at G2/M, or left nonsynchronized. See Figure S2A for relative quantita
(B) Astrin-deficiency-induced S6K1 phosphorylation is inhibited by the mTOR inhi
rapamycin, or carrier (DMSO); and induced with insulin/aa.
(C) Astrin deficiency induces IRS-1 phosphorylation. Treatment as in Figure 2B.
(D) The dynamic of mTORC1 (S6K1 phosphorylation) induction and NFL activatio
Figure 2B. See Figure S2A for relative quantitation of S6K1-T389.
(E) Astrin deficiency induces mTOR-raptor association in response to insulin/aa.
raptor and mTOR (red).
(F) Relative quantitation of mTORC1 assembly in situ in response to insulin/aa w
mean ± SEM.
Data representative of at least three independent experiments. See also Figure S
862 Cell 154, 859–874, August 15, 2013 ª2013 Elsevier Inc.binding (Figure S1D), but the increased raptor levels in astrin
overexpressing cells did not allow a clear result. In contrast,
siAstrin did not affect raptor levels (Figure 1E). Thus, based on
increased mTOR-raptor association in siAstrin cells, measured
by both IP and PLA, we conclude that astrin competes with
mTOR for raptor binding, resulting in increased mTORC1 forma-
tion in the absence of astrin.
Astrin Inhibits mTORC1 Signaling
Astrin has been described as a regulator of mitotic progression
(Chang et al., 2001; Gruber et al., 2002; Mack and Compton,
2001). mTORC1 has also been proposed to have a role in mitosis
(Gwinn et al., 2010; Nakashima et al., 2008; Ramı´rez-Valle et al.,
2010). We therefore tested whether astrin deficiency alters
mTORC1 activity during mitosis. We arrested HeLa cells at
G2/M with nocodazole and found that S6K1-T389 was only
weakly phosphorylated and remained unaltered upon astrin
knock down (Figure 2A). In contrast, astrin deficiency induced
S6K1-pT389 in nonsynchronized cells (Figure 2A, lane 1 and 3,
and Figure S2A, left), suggesting a regulatory role of astrin
toward mTORC1 outside of mitosis. To rule out that astrin siRNA
itself might increase the number of mitotic cells, we analyzed
histone H3-S10 phosphorylation and polo-like-kinase 1 (Plk1)
levels. None of these mitotic markers were induced by siAstrin
(Figure S2B), consistent with findings of others (Halim et al.,
2013). To ensure that astrin knockdown reproduces the
described mitotic effects (Thein et al., 2007), we confirmed that
also in our hands, nocodazole-induced histone H3-S10 phos-
phorylation was increased by astrin deficiency. We also tested
five different shRNA clones against astrin and comparable
results were obtained (Figure S2C). Of note, astrin-raptor binding
was lost in nocodazole-arrested mitotic cells (Figure S2D),
further pointing toward a function of the raptor-astrin complex
outside of mitosis. We conclude that astrin deficiency in non-
synchronized cells induces phosphorylation of the mTORC1
substrate S6K1-T389, and this effect is independent of astrin’s
mitotic functions.
To further investigate the role of astrin in mTORC1 signaling,
we examined insulin induction of mTORC1 in cells lacking
astrin. Astrin knockdown enhanced S6K1-T389 phosphorylation
(Figure 2B and S2A, right). The mTORC1-specific inhibitor rapa-
mycin and the mTORC1/2 inhibitor PP242 (Benjamin et al.,
2011), both potently inhibited S6K1-pT389 in astrin-deficient
cells. Thus, astrin’s inhibitory effect on S6K1-pT389 is mTORC1
dependent.k Loop toward the Insulin Receptor Substrate IRS-1
duces p70-S6K1-pT389 in nonsynchronized cultures. HeLa cells were syn-
tion of S6K1-T389 without and with siAstrin under basal conditions.
bitors rapamycin and PP242. HeLa cells serum/aa starved; treated with PP242,
n (IRS-1 phosphorylation) is accelerated by astrin deficiency. Treatment as in
Treatment as in Figure 2B. Nuclei stained with DAPI (blue); PLA performed for
ithout and with astrin siRNA (E). Dots/cell were counted. Data represented as
2.
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S6K1 phosphorylates IRS1-S636/639 to inhibit IRS1 (i.e.,
the NFL). In line with activated mTORC1 and S6K1 upon astrin
deficiency, we found IRS1-pS636/639 induced by astrin
siRNA (Figure 2C). Time course experiments upon insulin
induction (Figure 2D) revealed that astrin deficiency accele-
rates the phosphorylation induction of the mTORC1 substrates
S6K1-T389 and PRAS40-S183 (5 min after induction in siAstrin
versus 7 min in control cells, respectively). siAstrin also
accelerated the onset of the NFL (IRS1-pS636/639), resulting
in suppression of S6K1-pT389 (decline at 7 min after induction
in siAstrin cells, as compared to steady state induction
up to 20 min after induction in control cells). PLA analysis
revealed an initial drop of mTOR-raptor association, which
remained low in control cells but increased in siAstrin cells
from 5 min after induction on (Figures 2E and 2F).Thus, overall
mTORC1 network dynamics are accelerated in the absence of
astrin, and this correlates with an increase in mTOR-raptor
association.
The Astrin-Raptor Complex Localizes to SGs
To address the cellular localization of the astrin-raptor com-
plex we generated recombinant GFP-astrin fusion constructs.
The modular structure of astrin with its N-terminal globular
head domain and the two C-terminal coiled-coil domains
(Gruber et al., 2002) led us to generate constructs for full-
length astrin (GFP-astrinfull length), the N-terminal head domain
(GFP-astrin1-481), and the C-terminal coiled-coil domains
(GFP-astrin482-1193) (depicted in Figure S3A). GFP-astrinfull length
localized to cytoplasmic granular structures that were also
visible by light microscopy (Figure 3A). Of note, C-terminal
GFP-astrin482-1193 localized to similar structures, whereas N-ter-
minal GFP-astrin1-481 showed a diffuse cytosolic localization
(Figure 3B). GFP-astrinfull length and N-terminal GFP-astrin1-481
copurified with raptor, whereas C-terminal GFP-astrin482-1193
only weakly associated with raptor (Figure 3C). This suggests
that astrin’s N-terminal head domain mediates primarily raptor
binding, whereas astrin’s C-terminal coiled-coil domains
mediate mainly its localization.Figure 3. Astrin and Raptor Relocalize to SGs upon Oxidative Stress
(A) GFP-astrin localizes into granular structures that are visible by light microscop
GFP-astrin (green) and Hoechst (blue). Cross-section through the horizontal and
(B) The C-terminal coiled-coil domains of astrin mediate its distinct localization.
detection by fluorescence microscopy.
(C) The N-terminal head domain of astrin binds to raptor. Cells expressing GFP-ast
(D) GFP-astrin colocalizes with the SG/PBmarker p54/DDX6. GFP-astrin (green), p
for IB detection of GFP-astrin and p54/DDX6 expression.
(E) GFP-astrin does not colocalize with the lysosomal marker Lamp2. GFP-astr
Figure S3B for IB detection of GFP-astrin expression.
(F) IB analysis of cells in (G) for astrin and G3BP1 expression, and oxidative stre
(G) Astrin localizes under arsenite stress into G3BP1 positive SGs. HeLa cells c
(green), and Hoechst (blue). White arrows: astrin-G3BP1 colocalization.
(H) IB analysis of cells in (J) for mTOR, astrin, and G3BP1 expression and oxidat
(I) HA-raptor colocalizes with astrin into G3BP1 positive SGs under arsenite stress
against astrin, G3BP1, and HA. Insert: blow-up of square (points of colocalization:
raptor (blue), astrin (magenta), G3BP1 (green); double overlay (white) of astrin (gre
raptor (magenta). Insert: blow-up of square. See Figure S3E for control in unstre
(J) mTOR does not colocalize with astrin or G3BP1 under arsenite stress. Arsenit
blow-up of square.
Data representative of at least three independent experiments. See also Figure S
864 Cell 154, 859–874, August 15, 2013 ª2013 Elsevier Inc.The granular GFP-astrin assemblies resemble the patterns
seen with overexpression of PB or SG components (Anderson
and Kedersha, 2009). Being in constant exchange with each
other, SGs and PBs share several components including the
protein p54/DDX6. GFP-astrinfull length (expression efficiency
shown in Figure S3B) colocalized with p54/DDX6 (Figure 3D).
The active mTOR-raptor complex localizes to lysosomes (San-
cak et al., 2010). In contrast, GFP-astrinfull length did not colocalize
with the lysosomal marker Lamp2 (Figure 3E), strengthening the
notion that mTOR and astrin bind raptor in a mutually exclusive
manner.
To analyze whether endogenous astrin localizes to SGs upon
stress, we treated cells with with arsenite (500 mM, 30 min). As
reported, arsenite induced an inhibitory phosphorylation of the
translation initiation factor eIF2a at S51 (Farny et al., 2009)
(Figure 3F). The commercial astrin antibody used in this study
detected GFP-astrin by immunofluorescence (IF) (Figure S3C),
and it detected astrin in mitotic cells at the spindle (Figure S3D),
corresponding to astrin’s published localization (Thein et al.,
2007). In nonstressed cells, endogenous astrin showed a micro-
tubuli pattern (Figure 3G, top and insert), as reported (Mack and
Compton, 2001). Upon arsenite the SGmarker G3BP1 (Tourrie`re
et al., 2003) localized to granular cytoplasmic structures, i.e.,
SGs, and astrin partially colocalized with G3BP1 (Figure 3G, bot-
tom and insert). HA-raptor colocalized with astrin and G3BP1
upon arsenite (Figure 3I), whereas no colocalization in granular
structures was observed in unstressed cells (Figure S3E).
mTOR did not colocalize with G3BP1 upon arsenite treatment
(Figure 3J; levels of all three proteins shown in Figure 3H).
Thus, upon arsenite, astrin and raptor, but not mTOR, colocalize
with SGs.
Does relocalization of the astrin-raptor complex to SGs under
oxidative stress reduce mTOR-raptor association? To test this,
we analyzed whether raptor binds G3BP1. G3BP1 associated
with raptor in situ, which was increased by arsenite stress
(Figures 4A, 4B, and S4A). We confirmed this finding by
G3BP1-raptor co-IP (Figures 4C and S4B), which was induced
by arsenite stress. Second, we tested astrin-G3BP1 associationy. GFP-astrinfull length in HeLa cells was detected by confocal microscopy. Left:
vertical plane. Right: light microscopy of granular GFP-astrin structures.
GFP-astrinfull length, GFP-astrin1-481, GFP-astrin482-1193 (green), Hoechst (blue);
rinfull length, GFP-astrin1-481, GFP-astrin482-1193, or GFPwere used for raptor IPs.
54/DDX6 (magenta), Hoechst (blue). Insert: blow-up of square. See Figure S3B
in (green), Lamp2 (magenta), Hoechst (blue). Insert: blow-up of square. See
ss induction (eIF2a-pS51).
ultivated in control and stress conditions (arsenite); astrin (magenta), G3BP1
ive stress induction (eIF2a-pS51).
. Columns 1–3: Cells transfected with HA-raptor, arsenite stressed, and stained
magenta arrow heads). Columns 4–6 (left to right): Triple overlay (white) of HA-
en) and HA-raptor (magenta); double overlay (white) of G3BP1 (green) and HA-
ssed cells.
e-stressed cells. mTOR (magenta), G3BP1 (green), with Hoechst (blue). Insert:
3.
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in situ, which was also increased by arsenite (Figures 4D, 4E, and
S4C).We confirmed this result with an astrin antibody of different
clonality (Figures S4D and S4E). Third, also astrin association
with raptor was increased by arsenite in situ (Figures 4F, 4G,
and S4F) and in co-IPs (Figure 4H and S4G). Thus, formation
of the raptor-astrin complex and its association with SGs is
induced by arsenite.
Astrin Inhibits mTOR-Raptor Association and Recruits
Raptor to SGs
As astrin competes with mTOR for raptor binding (Figures 1E–
1H), stress conditions that induce the astrin-raptor complex (Fig-
ures 4F–4H) may reduce mTORC1 levels. Indeed arsenite
reduced raptor-mTOR association, in situ (Figures 4I and 4J)
and in co-IPs (Figures 4K and S4B). This is in agreement with
earlier studies (Sarbassov and Sabatini, 2005; Yoshida et al.,
2011) reporting that oxidative stress disassembles mTORC1.
We conclude that raptor-astrin association with SGs correlates
with mTOR-raptor disassembly.
Is astrin responsible for raptor recruitment to SGs and for
reduced mTOR-raptor association? Indeed, astrin inhibition
under arsenite stress reduced raptor-G3BP1 association in
co-IPs (Figures 5A and S5A) and in situ (Figures 5B, 5D, and
S5B), and astrin knockdown induced the mTOR-raptor complex
(Figures 5C, 5D and S5C). Thus, astrin is required for raptor
recruitment to SGs.
We next tested whether these effects were also observable
using another SG-inducing stressor. Hydrogen peroxide
(H2O2) induces SGs (Emara et al., 2012). We repeated the
above experiments with 2 mM H2O2, which reproduced the
results obtained with arsenite (Figure 5D). We also further
confirmed the astrin dependency of raptor-SG association by
monitoring another SG marker, eukaryotic initiation factor 3
(eIF3) (Kedersha and Anderson, 2007) (Figures 5E and 5F). In
agreement with the data for G3BP1 (Figures 5A, 5B, and 5D),
arsenite induced raptor-eIF3 association, which was ablated
by astrin knockdown (Figures 5E and 5F). We also analyzedFigure 4. Oxidative Stress Induces Astrin-Raptor Association in SGs a
(A) Raptor associates with G3BP1 in situ, and the association is induced by arse
(B) Relative quantitation of (A), raptor-G3BP1 association without and with arsen
(box), 5th–95th percentile (whiskers). See Figure S4A for quantitation of fluoresce
(C) Relative quantitation of coimmunoprecipitated G3BP1with raptor, without and
G3BP1 signals quantified and normalized to the raptor signal for n = 3 experim
mean ± SEM.
(D) Astrin associates with G3BP1 in situ, and the interaction is induced by arsenit
(red). See also Figures S4D and S4E.
(E) Relative quantitation of (D), astrin-G3BP1 association without and with arsen
(box), 5th–95th percentile (whiskers). See Figure S4C for quantitation of fluoresce
(F) Arsenite stress induces raptor-astrin association in situ. PLA for astrin and ra
(G) Relative quantitation of (F), raptor-astrin associationwithout andwith arsenite s
5th–95th percentile (whiskers). See Figure S4F for quantitation of fluorescence int
(H) Astrin co-IP with raptor is induced upon arsenite stress. IPs detected by IB
normalized to the raptor signal for n = 3 experiments. astrin/raptor ratio set to 1
(I) Decreased raptor-mTOR (mTORC1) association in situ upon arsenite stress. P
(J) Relative quantitation of (I), raptor-mTOR (mTORC1) assembly. Dots/cell coun
(whiskers).
(K) mTOR co-IP with raptor (mTORC1) is reduced upon arsenite stress. IPs de
quantified and normalized to the raptor signal for n = 3 experiments. mTOR/rapt
Data representative of at least three independent experiments. See also Figure S
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We found by PLA that in control cells (Figures S5D and S5E)
or arsenite stressed cells (Figures S5F, S5G–S5I) roughly
one third of the cellular raptor molecules associated with
mTOR or astrin, respectively, contributing to mTOR complex
stoichiometry.
Astrin-Mediated Inhibition of mTORC1 under Stress
Is SG Dependent
What is the function of astrin-mediated raptor recruitment to
SGs? SG formation (Figure 6A) and G3BP1 expression (Fig-
ure 6B) still occurred in the absence of astrin. Also in raptor-
deficient cells we did not detect an apparent reduction of SG
formation (Figures 6C and 6D). Hence, under the conditions
tested here, SG formation did not require astrin or mTORC1.
Next, we analyzed whether astrin and SGs exert an inhibitory
effect on mTORC1. Whereas loss of TSC1-TSC2 induces
mTORC1 kinase activity upon stress (Yoshida et al., 2011), the
here-observed mTOR-raptor dissociation may be a compen-
satory mechanism to prevent mTORC1 hyperactivation. In
agreement with this hypothesis and published data (Wang
and Proud, 1997), arsenite per se induced S6K1-T389 phos-
phorylation, which was inhibited by rapamycin (Figure 6E) or
raptor shRNA (Figure 6F). Astrin inhibition further induced
S6K1-T389 phosphorylation upon arsenite (Figure 6G) by 37%
(Figure S6A), which was inhibited by PP242 (Figure 6H) or
rapamycin (Figure S6B). Thus, astrin inhibition induces mTORC1
upon oxidative stress. A time course analysis revealed that
astrin deficiency led to stronger and more sustained S6K1-
pT389 induction, whereas stronger induction of the other
mTORC1 substrate 4E-BP1-pT37/46 became apparent from
40 min after induction on (Figure 6I). This is in line with recent
studies reporting that mTORC1 substrates respond to mTORC1
induction with differential context-dependent, temporal dy-
namics (Dennis et al., 2013; Rapley et al., 2011). We found
that also heat shock, an alternative SG-inducing stress, led
to enhanced S6K1-pT389 induction in astrin-deprived cellsnd Reduces Raptor-mTOR association
nite. DAPI (blue), and PLA for raptor and G3BP1 (red).
ite stress. Dots/cell counts. Data represented as median, 25th–75th percentile
nce intensity.
with arsenite stress. IPs detected by IB (representative example in Figure S4B).
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(Figure S6C). Thus, astrin prevents mTORC1 hyperactivation
under conditions that induce SGs.
Because mTORC1 is active at lysosomes, we tested whether
astrin affects raptor-Lamp2 association. Astrin knockdown
induced raptor-Lamp2 association in control cells (Figures 6J
and 6K), which was in line with mTORC1 induction by siAstrin
under basal conditions or insulin/aa stimulation (Figures 2 and
S2A). Arsenite decreased raptor-Lamp2 association, and this
remained unchanged in siAstrin cells (Figures 6J and 6K). This
finding is in agreement with a recent study reporting the loss of
raptor-lysosome colocalization under stress (Wippich et al.,
2013). Thus, mTORC1 under stress may be active at a site other
than lysosomes, raising the possibility of a novel yet unknown
mechanism of mTORC1 activation.
Does the inhibitory effect of astrin toward mTORC1 under
stress require SGs? To test this, we combined arsenite stress
with short term (30 min) cycloheximide (chx) treatment, which
stalls mRNA in polysomes and inhibits SG assembly (Kedersha
and Anderson, 2007). We confirmed this in our system by
cotreating cells with arsenite and chx, followed by IF analysis
of G3BP1 (Figure 7A). Next, we tested the effect of SG inhibi-
tion on mTORC1 activity. Chx combined with arsenite strongly
induced S6K1-pT389, and under these conditions, shAstrin
failed to further induce mTORC1 activity (Figure 7B). Chx alone
after 30 min did not have a stimulating effect on mTORC1. We
repeated the experiment with H2O2 and obtained similar re-
sults (Figures 7C, 7D, and S6A, right). Thus, prevention of
mTORC1 hyperactivation by astrin under oxidative stress is
SG dependent. In addition, we tested emetine, another trans-
lation inhibitor that stabilizes polysomes and thereby inhibits
SGs (Kedersha et al., 2000) (Figures S7A and S7B). Like chx,
also emetine further induced mTORC1 under oxidative stress
in siControl but not in siAstrin cells. As chx and emetine not
only inhibit SGs but also translation, we tested hippuristanol
(Bordeleau et al., 2006) and puromycin (Kedersha et al.,
2000), two translation inhibitors, which destabilize polysomes
and thereby induce SG assembly (Anderson and Kedersha,
2008), for their effects on mTORC1 induction by shAstrin (Fig-
ures S7B, S7C, and S7D). Both hippuristanol and puromycin
failed to further induce the mTORC1 readout S6K1-pT389
but rather inhibited mTORC1, ruling out that translational arrest
alone induced mTORC1. It should be noted that astrin inhibi-
tion did not affect raptor levels and vice versa (Figure 7E),
ruling out that altered raptor or astrin levels add to the
observed effects. Thus, SGs are required for astrin’s inhibitoryFigure 5. Astrin Is Required for Raptor Recruitment to SGs upon Redo
(A) Astrin siRNA reduces raptor-G3BP1 co-IP under arsenite stress. IPs detected
and normalized to the raptor signal for n = 3 experiments. G3BP1/raptor ratio se
(B) Relative quantitation of (D), raptor-G3BP1 association without and with astr
25th–75th percentile (box), 5th–95th percentile (whiskers). See Figure S5B for qua
(C) Relative quantitation of (D), combined arsenite and astrin siRNA effects on mTO
25th–75th percentile (box), 5th–95th percentile (whiskers). See Figure S5C for qua
(D) Oxidative stress induced by H2O2 reproduces the effects of arsenite stress
without and with astrin siRNA. PLA (red); DAPI (blue).
(E) Astrin mediates raptor binding to the SG marker and translation initiation fact
(F) Relative quantitation of (E), raptor-eIF3 association without and with astrin siRN
percentile (box), 5th–95th percentile (whiskers).
Data representative of at least three independent experiments. See also Figure S
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stress.
SG andAstrin-DependentmTORC1Repression Protects
Cancer Cells from Oxidative Stress-Induced Apoptosis
Redox stress is a common condition in tumors, and tumor cells
need to evade apoptosis in response to oxidative insults (Frue-
hauf and Meyskens, 2007; Sosa et al., 2013). Of note, hyperac-
tive mTORC1 signaling sensitizes cells to apoptosis (Shah
et al., 2004; Lee et al., 2007), and astrin deficiency facilitates
apoptosis (Gruber et al., 2002). Is enhanced apoptosis in
astrin-deficient cells mediated by loss-of-astrin-induced
mTORC1 hyperactivation? Indeed, siAstrin enhanced apoptosis
in H2O2 treated HeLa cells, as measured by cleaved PARP (poly
[ADP-ribose] polymerase) (Figure 7E). Apoptosis induced by loss
of astrin was inhibited by shRaptor (Figure 7E). We conclude that
mTORC1 activity restriction by astrin protects HeLa cells against
apoptosis. Does this finding translate to other cancer cells?
siAstrin facilitated PARP cleavage also in several breast cancer
cell lines (Figure S7E). In MCF-7 breast cancer cells apoptosis
sensitization by astrin deficiency was phenocopied by SG inhibi-
tion (Figure 7F), and mTORC1 inhibition prevented apoptosis in
astrin-deficient cells (Figure 7G). SG inhibition by chx facilitated
apoptosis, and under this condition, astrin depletion could not
further enhance apoptosis (Figure 7F). Rapamycin suppressed
apoptosis in siAstrin cells (Figure 7G). We confirmed this by
live-cell imaging to determine the onset of apoptotic membrane
blebbing (Wickman et al., 2012) (Figures 7H and 7I and Movies
S1 and S2). Membrane blebbing occurred in siAstrin cells
already at ca. 100 min after H2O2, as compared to 200 min in
control cells (Figure 7H and Movie S1). Chx reduced blebbing
onset in control cells to 100 min, whereas no further reduction
was observed in siAstrin cells. In contrast, rapamycin delayed
the mean onset of blebbing in siAstrin cells by 50 min (Figure 7I
and Movie S2). Our data are consistent with a model in which
astrin in a SG-dependent manner restricts mTORC1 activity to
prevent mTORC1 hyperactivation and apoptosis upon oxidative
stress. One mechanism for apoptosis suppression in cancer
cells is Akt-mediated inhibition of the transcription factors
FoxO1/3A (Myatt et al., 2011); Akt is inhibited by the mTORC1-
dependent NFL. In line with this, we observed that mTORC1 in-
hibition by rapamycin-induced FoxO1/3A phosphorylation and
repressed oxidative stress and siAstrin-induced apoptosis (Fig-
ure 7G). In summary, astrin inhibits apoptosis in cancer cells by
preventing mTORC1 hyperactivation upon oxidative stress.x Stress
by IB (representative example shown in Figure S5A). G3BP1 signals quantified
t to 1 for control treatment. Data represented as mean ± SEM.
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DISCUSSION
Wippich et al. (2013) recently reported that SGs inhibit mTORC1
via sequestration of mTORC1 components. In this study, we
identify astrin as a molecular link enabling mTORC1 regulation
by SGs under oxidative stress in mammalian cells (summarized
in Figure 7J). Already a decade ago Kim et al. (2002) observed
that conditions that inhibit the mTORC1 pathway correlate with
a stronger mTOR-raptor association and vice versa. Our study
reveals astrin as a key factor that inhibits mTORC1 association,
and this mechanism restricts mTORC1 activity in metabolically
challenged cells to prevent mTORC1 hyperactivation-induced
apoptosis.
Redox activation of mTORC1 is mediated by inactivation of
TSC1-TSC2, in a PI3K- and Akt-independent manner (Yoshida
et al., 2011). Accordingly, we observed that mTORC1 induction
by arsenite stress and mTORC1 hyperactivation by siAstrin still
occurred when PI3K and Akt induction were inhibited (Fig-
ure S7F). Furthermore, TSC2 was downregulated upon arsenite
stress, which correlated with induced S6K1-pT389 (Figure S7G).
This supports TSC1-TSC2 inhibition as a transducer of activating
redox signals to mTORC1. Consequently, another component,
i.e., astrin, needs to take over as an mTORC1 inhibitor, so that
the cell retains mTORC1 under control. Notably, we found that
TSC2 deprivation induced astrin protein levels (Figure S7H).
Therefore, TSC1-TSC2 suppression may not only induce
mTORC1 in response to redox; but TSC1-TSC2 deficiency
may also upregulate the levels of astrin thereby allowing to main-
tain mTORC1 in check.
Why does mTORC1 need to be active upon oxidative stress?
Although overall cellular translation is reduced, proteins required
for the cellular stress response need to be expressed (Yamasaki
and Anderson, 2008). Translation under stress depends on up-
stream open reading frames (uORF) and internal ribosomal entry
sites (IRES) (Holcik and Sonenberg, 2005). mTORC1 induces
both IRES-mediated (Dai et al., 2011; Grzmil and Hemmings,
2012) and uORF-dependent translation (Ramı´rez-Valle et al.,
2008), and both mTORC1 and SGs control translation of stress
related factors (Buchan and Parker, 2009; Chou et al., 2012;
Hsieh et al., 2012; Huo et al., 2012; Thoreen et al., 2012). Accord-
ingly, we report that several stress related proteins (HSF1,
hnRNP-A1, and Hsp70) require mTORC1 for their expression
upon arsenite stress (Figure S7G). hnRNP-A1 mediates IRES-Figure 6. Astrin Inhibits mTORC1 under Oxidative Stress
(A) Astrin siRNA does not prevent SG assembly under oxidative stress. G3BP1 (
(B) IB analysis of (A) for astrin siRNA efficiency, G3BP1 expression, and oxidativ
(C) Raptor shRNA does not prevent SG assembly under oxidative stress. G3BP1
(D) IB analysis of (C) for raptor shRNA efficiency, G3BP1 expression, and oxidati
(E) Arsenite stress induces phosphorylation of the mTORC1 substrate S6K1-T38
(F) Raptor shRNA inhibits phosphorylation of S6K1-T389 under arsenite stress.
(G) Astrin siRNA further induces S6K1-T389 under arsenite stress. See Figure S6
(H) PP242 inhibits induction of S6K1-T389 by arsenite stress and astrin siRNA. S
(I) Astrin siRNA induces differential phosphorylation of the mTORC1 substrates S
(J) Relative quantitation of (K), raptor-Lamp2 association without and with astri
25th–75th percentile (box), 5th–95th percentile (whiskers).
(K) Astrin deficiency induces raptor association with the lysosomal marker Lamp2
stress. PLA (red) for Lamp2 and raptor; DAPI (blue).
Data representative of at least three independent experiments. See also Figure S
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whereas HSF1 mediates transcriptional events, including
Hsp70 expression (Chou et al., 2012). In contrast, activating tran-
scription factor ATF-4 (its mRNA containing two uORFs, Vattem
and Wek, 2004) is repressed by mTORC1 under nonstress con-
ditions, but constitutively expressed when raptor is absent (Fig-
ure S7G). Thus, mTORC1 differentially controls expression of
stress related proteins.
One effect of astrin-mediated mTORC1 inhibition is the inacti-
vation of the mTORC1-dependent NFL. In turn, Akt activation is
well known to prevent apoptosis (Appenzeller-Herzog and Hall,
2012). In healthy cells astrin-mediated inhibition of apoptosis
may be beneficial as it prevents cells from undergoing apoptosis
upon transient stresses or metabolic challenge. In contrast, in
cancer cells astrin-mediated mTORC1 and apoptosis suppres-
sion can become detrimental as it prevents overgrowing cells
from undergoing apoptosis. Notably, astrin is highly expressed
in tumor cells (Buechler, 2009; Va¨lk et al., 2010) and spermato-
cytes (Shao et al., 2001). Hence, astrin inhibition may allow
modulation of mTOR network activity specifically in tumor cells,
opening new avenues to cancer therapy.
Of note, the growth factor insulin controls protein transla-
tion via SGs (Karimian Pour and Adeli, 2011), suggesting that
SGs play a role beyond stress. Our data support a general
role of SGs in so far as we have identified astrin as a raptor
interactor in unstressed cells (Figure 1), astrin inhibition
induces mTORC1 assembly in both stressed and unstressed
cells (Figure 5D), and the integral SG component eIF3 binds
raptor also in unstressed cells in an astrin-dependent manner
(Figure 5E).
Two studies (Takahara andMaeda, 2012; Wippich et al., 2013)
report association of TOR/mTOR itself with the late SG marker
Pbp-1/PABP1 (Anderson and Kedersha, 2008). The early SG
marker G3BP1 did not colocalize with mTOR in our study.
Thus, mTORC1 regulation by SGs may involve mTOR at later
stages of SG assembly. In contrast to our data (Figure 6C), Four-
nier et al. (2013) reported that mTORC1 positively controls SG
formation. The authors used a low arsenite concentration that
did not activate mTORC1, which may enable the observation
of mTORC1-dependent SG assembly.
It has been suggested that astrin deficiency leads to
mitotic delay, due to a defective spindle check point (Gruber
et al., 2002; Thein et al., 2007). Notably, mitotic defects inwhite), Hoechst (blue).
e stress induction (eIF2a-pS51).
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astrin-deficient cells are only detectable upon prolonged noco-
dazole treatment (Manning et al., 2010). Accordingly, and in line
with others (Halim et al., 2013), we did not detect increased
mitotic markers in nonsynchronized, astrin-deficient cells (Fig-
ure S2B). In turn, we observed mTORC1 induction by astrin
knock down in nonsynchronized, but not in mitotic cells (Fig-
ure 2A). This suggests that astrin’s effects on mitosis and on
mTORC1 are two separate functions. This is underlined by
our finding that G3BP1 binding to raptor is lost in cells arrested
at G2/M by nocodazole or the Plk1 inhibitor GW 843682X (Fig-
ure S7I). We demonstrate in the present study that increased
apoptosis in astrin-deficient cells can be suppressed by
mTORC1 inhibition (Figure 7E, 7G, and 7I). Thus, our results
unify and explain earlier reports on increased apoptosis upon
astrin deficiency by showing that astrin-sensitive apoptosis is
due to aberrant mTORC1 induction.
EXPERIMENTAL PROCEDURES
Cell Lines and Tissue Culture
Details on constructs and reagents can be found in the Extended Experimental
Procedures. Insulin/aa induction was performed as described (Sonntag et al.,
2012). Doxycycline (for shRNA induction) was removed over night prior to ex-
periments. Prior to stress induction (500 mMarsenite or 2mMH2O2), cells were
starved for 16 hr in DMEM without glucose or fetal calf serum. SGs were
analyzed after 30 min stress induction. Apoptosis was analyzed after 1–3 hr
arsenite or H2O2. HeLa cells were synchronized with nocodazole (400 ng/ml)
and subsequent mitotic shake off, and released as described (Thein et al.,
2007).
Mass Spectrometry
Identification of novel mTOR and raptor interactors was performed as
described (Thedieck et al., 2007).
Lysis, IP, and Immunoblotting
Lysis, IP, and immunoblotting (IB) were described elsewhere (Dalle Pezze
et al., 2012;). See Extended Experimental Procedures for details on antibodies.
IF, Fluorescence Microscopy, and Confocal Microscopy
IF and PLA were performed as described (Thedieck et al., 2007; Thein et al.,
2007; So¨derberg et al., 2008). Scale bars are 10 mm. See Extended Experi-
mental Procedures for detailed protocols.
Quantitations and Statistics
All experiments were performed in at least n = 3 replicates. Comparison of
two groups was analyzed by nonparametrical two-tailed Student’s t testFigure 7. SGs Are Required for mTORC1 Inhibition by Astrin under Ox
Protects Cells from Oxidative Stress-Induced Apoptosis
(A) Cycloheximide (chx) prevents arsenite-induced SG formation. Fluorescence m
(B) Chx suppresses the astrin shRNA effect on S6K1-pT389 induction under arse
(C) Chx prevents H2O2-induced SG formation. Fluorescence microscopy, G3BP1
(D) Chx suppresses the astrin shRNA effect on S6K1-pT389 induction under H2O
(E) siAstrin sensitizes cells to apoptosis, which is prevented by mTORC1 inhibitio
(F) siAstrin sensitizes breast cancer cells to apoptosis in the presence but not in t
Figure S7E.
(G) siAstrin sensitizes breast cancer cells to mTORC1-dependent apoptosis. MC
(H) siAstrin leads to early onset of apoptosis in the presence but not in the absence
onset indicated. Data represented as mean ± SEM. See also Movie S1.
(I) Early onset of apoptosis in siAstrin cells is suppressed by mTORC1 inhibitio
blebbing onset indicated. Data represented as mean ± SEM. See also Movie S2
(J) Schematic representation of astrin- and SG-mediated mTORC1 inhibition and
Data representative of at least three independent experiments. See also Figure S
872 Cell 154, 859–874, August 15, 2013 ª2013 Elsevier Inc.assuming unequal variances. For multiple groups, statistical significance
was analyzed by 1-way ANOVA. See Extended Experimental Procedures for
details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two movies and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.07.031.
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